
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
- Volume 11
- Issue 6
Patheon Appoints Michel Lagarde President
Lagarde will be based out of the company’s Boston office and will lead Patheon’s global corporate and cross-enterprise operations.
On May 31, 2016, Patheon
Lagarde joins Patheon from JLL Partners, a middle market private equity firm. For the past eight years, he has been working with several of JLL’s portfolio companies, including Patheon, in the healthcare and pharma services sectors as managing director. He has served as a member of Patheon’s Board of Directors since 2011. As a result of his appointment, Lagarde has stepped down from his position on Patheon’s Board of Directors.
Source:
Articles in this issue
about 10 years ago
Slow Serialization Efforts May Delay Business Benefitsabout 10 years ago
Scientific Approach Ensures Accurate Weighing Resultsabout 10 years ago
Ensuring Biologic API Uniformityabout 10 years ago
Biomanufacturing Outsourcing Budgets Grow, Slowlyabout 10 years ago
Novasep Starts Kilogram-Scale Batch Production at US Facilityabout 10 years ago
FUJIFILM Opens New Laboratory in North Carolinaabout 10 years ago
Catalent Opens Korean Sales Officeabout 10 years ago
Juniper Pharma Services Expands Topicals Capacityabout 10 years ago
ED-XRF Spectrometers Offer Rapid Elemental Analysisabout 10 years ago
Raman Microscope Measures Uneven Surfaces



